At close: December 20 at 5:29:55 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
1,888.0000
3,554.0000
345.0000
Operating Expense
22,674.0000
40,674.0000
38,506.0000
40,824.0000
32,670.0000
Operating Income
-22,642.0000
-40,674.0000
-36,618.0000
-37,270.0000
-32,325.0000
Net Non Operating Interest Income Expense
692.0000
468.0000
-243.0000
--
-8.0000
Pretax Income
-21,952.0000
-40,206.0000
-36,860.0000
-37,270.0000
-32,334.0000
Net Income Common Stockholders
-21,959.0000
-40,206.0000
-36,860.0000
-37,270.0000
-32,334.0000
Diluted NI Available to Com Stockholders
-21,959.0000
-40,206.0000
-36,860.0000
-37,270.0000
-32,334.0000
Basic EPS
-0.25
-0.63
-1.07
-1.08
-1.12
Diluted EPS
-0.25
-0.63
-1.07
-1.08
-1.12
Basic Average Shares
112,061.6870
63,456.0000
34,396.0000
34,441.9530
28,913.2110
Diluted Average Shares
136,463.3260
63,456.0000
34,396.0000
34,441.9530
28,913.2110
Total Operating Income as Reported
-22,642.0000
-40,674.0000
-36,617.0000
-37,269.0000
-32,326.0000
Rent Expense Supplemental
--
--
--
--
708.0000
Total Expenses
22,642.0000
40,674.0000
38,506.0000
40,824.0000
32,670.0000
Net Income from Continuing & Discontinued Operation
-21,959.0000
-40,206.0000
-36,860.0000
-37,270.0000
-32,334.0000
Normalized Income
-21,959.0000
-40,206.0000
-36,860.0000
-37,270.0000
-32,334.0000
Interest Income
793.0000
529.0000
19.0000
--
--
Interest Expense
101.0000
61.0000
262.0000
--
8.0000
Net Interest Income
692.0000
468.0000
-243.0000
--
-8.0000
EBIT
-21,851.0000
-40,145.0000
-36,598.0000
-37,270.0000
-32,326.0000
EBITDA
-5,913.0000
-24,457.0000
-36,114.0000
-36,806.0000
-31,838.0000
Reconciled Depreciation
-178.0000
475.0000
484.0000
464.0000
488.0000
Net Income from Continuing Operation Net Minority Interest
-21,959.0000
-40,206.0000
-36,860.0000
-37,270.0000
-32,334.0000
Normalized EBITDA
-5,913.0000
-24,457.0000
-36,114.0000
-36,806.0000
-31,838.0000
12/31/2020 - 7/31/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NANECH.ST NanoEcho AB
0.1580
+21.54%
QUIA.ST Quia Pharma AB (publ)
0.0172
+3.61%
COMBI.ST CombiGene AB (publ)
2.7200
+5.43%
DIABIO.ST Diagonal Bio AB (publ)
0.0258
+5.31%
PCIB.OL PCI Biotech Holding ASA
1.3200
-7.04%
ZICC.ST Ziccum AB (publ)
0.3830
-6.36%
CRNA.OL Circio Holding ASA
0.7080
-3.28%
ULTI.OL Ultimovacs ASA
2.5500
-3.77%
FLUI.ST Fluicell AB (publ)
0.0412
-1.90%
ISOFOL.ST Isofol Medical AB (publ)
2.4050
-3.80%